BONE MINERAL DENSITY IS STABLE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY RECEIVING LONG-TERM TREATMENT WITH MITAPIVAT

EHA Library, Hanny Al-Samkari, 325456

WARM AUTOIMMUNE HEMOLYTIC ANEMIA IS ASSOCIATED WITH A REGULATORY T CELL DEFICIENCY AND A TH17 POLARIZATION

EHA Library, Marion Ciudad, 325457

SEVERE NEONATAL HAEMOLYTIC ANAEMIA AND SPHEROCYTIC-ELLYPTOCYTOSIS PHENOTYPE DUE TO THE INTERACTION OF THREE NOVEL SPTA1 MUTATIONS

EHA Library, Joan-Lluis Vives-Corrons, 325458

PYRUVATE KINASE DEFICIENCY IN THE RUSSIAN FEDERATION: AN OVERVIEW OF CLINICAL CHARACTERISTICS AND MOLECULAR DEFECTS.

EHA Library, Ekaterina Cherniak, 325459

MOLECULAR HETEROGENEITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY IN PORTUGAL

EHA Library, Licinio Manco, 325460

SYMPTOMATIC BONE MARROW RECONVERSION: A COMMON FEATURE IN HEREDITARY SPHEROCYTOSIS ?

EHA Library, Camille Pochard, 325461

SOLUBLE CTLA-4 IN CHILDREN WITH IMMUNE CYTOPENIAS: RELATION TO DISEASE ACTIVITY

EHA Library, Sara Makkeyah, 325462

IDENTIFICATION OF A WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA) POPULATION USING PREDICTIVE ANALYTICS OF A KNOWN CLINICALLY PROFILED COHORT

EHA Library, Keith McCrae, 325463

CLINICAL FEATURES AND TREATMENT RESPONSES IN PEDIATRIC PATIENTS WITH WARM ANTIBODY IMMUNE HEMOLYTIC ANEMIA

EHA Library, Yesim Oymak, 325464

AUTOIMMUNE HEMOLYTIC ANEMIA ASSOCIATED WITH LYMPHOID MALIGNANCIES: REPORT FROM A FRENCH PROSPECTIVE REGISTER.

EHA Library, Sylvain Audia, 325465

FACIT-FATIGUE SUBSCALE OUTCOMES FROM AN ONGOING PHASE 2, OPEN-LABEL STUDY OF THE PHOSPHATIDYLINOSITOL 3-KINASE DELTA (PI3KΔ) INHIBITOR PARSACLISIB IN PATIENTS WITH AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

EHA Library, Fabrizio Pane, 325466

CLINICAL AND MOLECULAR CHARACTERISTICS OF IMERSLUND‐GRÄSBECK SYNDROME: FIRST REPORT OF A NOVEL FRAMESHIFT VARIANT IN EXON 11 OF AMN GENE

EHA Library, Mohamed Elshinawy, 325467

USE OF AN NGS PANEL FOR DE DIAGNOSIS OF HEREDITARY HEMOLYTIC ANEMIAS

EHA Library, Irene Zamanillo, 325468

INFLAMMATION AND FATIGUE IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): ANALYSIS FROM THE PHASE 3 CARDINAL STUDY

EHA Library, Ilene Weitz, 325469

MORTALITY AMONG VETERANS WITH A DIAGNOSIS OF PYRUVATE KINASE DEFICIENCY: A REAL-WORLD STUDY USING US VETERANS HEALTH ADMINISTRATION DATA

EHA Library, Erin Zagadailov, 325470

FEASIBILITY STUDY: USING DRIED BLOOD SPOTS AS A DNA SOURCE TO SCREEN FOR PYRUVATE KINASE CAUSING VARIANTS

EHA Library, Barnaby Clark, 325471

USEFULNESS OF NGS TECHNIQUES FOR PYRUVATE KINASA DEFICIENCY (PKD) DIAGNOSIS IN SPAIN

EHA Library, Marta Morado, 325472

STUDY DESIGN OF A PHASE 2/3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN ANTAGONIST, IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA)

EHA Library, Irina Murakhovskaya, 325473

WARM AUTOIMMUNE HEMOLYTIC ANEMIA : A RETROSPECTIVE ANALYSIS OF 115 PATIENTS

EHA Library, BECHIR ACHOUR, 325474

COMPARISON BETWEEN THE DIFFERENT REGIMENS AND PHARMACOLOGICAL FORMS OF CORTICOSTEROID AS FIRST-LINE THERAPY OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA): RESULTS OF THE PROSPECTIVE OBSERVATIONAL COHORT.

EHA Library, Ghada Abdallah, 325475

PHENOTYPIC, TRANSCRIPTIONAL AND FUNCTIONAL ANALYSIS OF CD19 CAR-T CELLS: SENESCENT/EXHAUSTED PHENOTYPE PREDICTS RESPONSE OF B CELL LYMPHATIC MALIGNANCIES

EHA Library, Katia Beider, 325476

IMMUNE REGULATORY PROTEINS MODULATE FIBROSIS AND INFLAMMATION IN SCLERODERMATOUS GRAFT-VS-HOST DISEASE

EHA Library, Gerlinde Wernig, 325477

IMPROVED LEUKEMIA CLEARANCE AFTER ADOPTIVE TRANSFER OF NK CELLS ENGINEERED WITH THE BONE MARROW HOMING RECEPTOR CXCR4

EHA Library, Filip Segerberg, 325478

HARNESSING EXHAUSTED, TUMOR-SPECIFIC T CELLS TO GENERATE A T-CELL RECEPTORS LIBRARY FOR ADOPTIVE T CELL THERAPY IN BLOOD MALIGNANCIES

EHA Library, Francesco Manfredi, 325479

VALIDATION OF AN IL-1RAP CART-CELLS PRECLINICAL « GMP-LIKE » PRODUCTION PROCESS BEFORE AN UPCOMING FIRST IN HUMAN PHASE I CLINICAL TRIAL.

EHA Library, Xavier Roussel, 325480

EXPLORING A SAFE AND EFFECTIVE 'OFF-THE-SHELF' CELL-BASED IMMUNOTHERAPY FOR THE TREATMENT OF MULTIPLE MYELOMA USING NON-IRRADIATED CAR NK-92MI CELLS

EHA Library, Elena Maroto Martín, 325481

CAR-TREG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS

EHA Library, Matteo Doglio, 325482

MONITORING COMMERCIAL ANTI-CD19 CAR T-CELL PRODUCT EXPANSION KINETICS: REAL-WORLD APPLICATIONS OF A NOVEL DROPLET DIGITAL PCR ASSAY AND OF MULTIPARAMETRIC FLOW CYTOMETRY

EHA Library, Chiara Monfrini, 325483

SELECTION, EXPANSION, AND NEW PRETREATMENT OF HUMAN NATURAL KILLER CELLS WITH ANTI-CD38 MONOCLONAL ANTIBODY FOR EFFICIENT TREATMENT OF MULTIPLE MYELOMA.

EHA Library, Juli R. Bagó, 325484

DETERMINANTS OF IN VIVO EXPANSION OF CD19 SPECIFIC CAR T-CELLS IN LARGE B-CELL LYMPHOMA: SINGLE CENTER IMMUNMONITORING RESULTS

EHA Library, Viktoria Blumenberg, 325485

MONITORING CAR-T CELL IN B-CELL LYMPHOMA PATIENTS THROUGH SINGLE CHAIN VARIABLE FRAGMENT QPCR

EHA Library, Diego Carbonell, 325486

CRISPR/CAS9 MEDIATED TCR EXCHANGE IN CORD BLOOD CD8+ T CELLS POTENTIALLY INCREASES GVL AND DECREASE GVHD

EHA Library, Vania Lo Presti, 325487

THE IMMUNOREGULATORY FUNCTIONS OF EXOSOME DERIVED FROM MESENCHYMAL STEM CELLS (MSCS) THAT GENETICALLY MODIFIED BY ADENO-ASSOCIATED VIRUS (AAV）

EHA Library, Li Liu, 325488

CAR-T CELL IN DIFFUSE LARGE B-CELL AND PRIMARY MEDIASTINAL LYMPHOMAS IN REAL LIFE SETTING: A REPORT FROM THE PROSPECTIVE OBSERVATIONAL STUDY OF THE ITALIAN SOCIETY OF HEMATOLOGY.

EHA Library, Annalisa Chiappella, 325489

CLINICAL OUTCOMES IN ADULTS WITH HEMOPHILIA B WITH AND WITHOUT PRE-EXISTING NEUTRALIZING ANTIBODIES TO AAV5: 6 MONTH DATA FROM THE PHASE 3 ETRANACOGENE DEZAPARVOVEC HOPE-B GENE THERAPY TRIAL

EHA Library, Frank Leebeek, 325490

IMMUNOTHERAPY USING A 3RD GENERATION CD20 TARGETED CAR T-CELL (MB-106) FOR TREATMENT OF B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Mazyar Shadman, 325491

CTX001 FOR TRANSFUSION-DEPENDENT Β-THALASSEMIA: SAFETY AND EFFICACY RESULTS FROM THE ONGOING CLIMB THAL-111 STUDY OF AUTOLOGOUS CRISPR-CAS9-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS

EHA Library, Franco Locatelli, 325492

FACTORS ASSOCIATED WITH PROGRESSION-FREE SURVIVAL (PFS) OF ADULT AND PEDIATRIC PATIENTS WITH RELAPSED / REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ARI-0001 CART19 THERAPY.

EHA Library, Valentín Ortiz-Maldonado, 325493

CTX001 FOR SICKLE CELL DISEASE: SAFETY AND EFFICACY RESULTS FROM THE ONGOING CLIMB SCD-121 STUDY OF AUTOLOGOUS CRISPR-CAS9-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS

EHA Library, Stephan Grupp, 325494

REAL-WORLD TREATMENT WITH CAR T-CELL THERAPY OF UNITED STATES (US) PATIENTS WITH LARGE B CELL LYMPHOMA (LBCL)

EHA Library, Andrew Klink, 325495

T CELL LINEAGE MIXED CHIMERISM IN ACUTE LEUKAEMIA/MDS- IS IT PROGNOSTIC - A SINGLE CENTRE RETROSPECTIVE STUDY

EHA Library, Vipul Sheth, 325496

OBJECTIVE RESPONSE AT LOW DOSE IN THE FIRST-IN-HUMAN IMMUNICY-1 TRIAL EVALUATING NON-GENE EDITED ALLOGENEIC CYAD-211 ANTI-BCMA CAR-T PRODUCT IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA

EHA Library, Sebastien Anguille, 325497

PRELIMINARY ANALYSIS OF A PHASE 1 STUDY OF NEXI-002 AUTOLOGOUS MULTI-AGENT-SPECIFIC CD8+ T CELLS FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Andrew Kin, 325498

A 10 YEAR RETROSPECTIVE SERIES OF PERIPHERAL BLOOD STEM AND PROGENITOR CELL COLLECTION IN PEDIATRIC CANDIDATES FOR AUTOLOGOUS EX-VIVO GENE THERAPY

EHA Library, Daniele Canarutto, 325499

DIFFERENCES IN SERUM CYTOKINE LEVELS AND PEAK TIMES BETWEEN CD19 AND CD7 CAR-T TREATMENT

EHA Library, Dongchu Wang, 325500

INTENTION TO TREAT VERSUS MODIFIED INTENTION-TO-TREAT ANALYSIS IN BCMA AND CD-19 CHIMERIC ANTIGEN RECEPTOR TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Ghulam Rehman Mohyuddin, 325501

LONG TERM CYTOPENIA AND INFECTIONS IN PATIENTS TREATED WITH ANTI-CD19 CAR T-CELLS: AN ANALYSIS OF BONE MARROW AND CLINICAL RISK FACTORS

EHA Library, Anna Guidetti, 325502

TOWARDS PATIENT-SPECIFIC DOSING OF MELPHALAN CONDITIONING FOR ARU-1801, A NOVEL GENE THERAPY FOR TREATMENT OF SICKLE CELL DISEASE

EHA Library, Brendan Johnson, 325503

FACILITY READINESS ASSESSMENT FOR CAR-T TREATMENT IN AUSTRALIA: NHL PERSPECTIVE

EHA Library, Pravin Bagul, 325504

ANAKINRA PROPHYLAXIS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ORVACABTAGENE AUTOLEUCEL (ORVA-CEL)

EHA Library, Luciano J. Costa, 325505

A PROSPECTIVE PHASE I/IIA TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (WINK TRIAL)

EHA Library, Jakob Passweg, 325506

'MYTCELL': A SMARTPHONE APPLICATION GUIDES MANAGEMENT OF CAR T-CELL & BITE RELATED TOXICITIES

EHA Library, Viktoria Blumenberg, 325507

DIFFERENTIAL HEMATOPOIETIC SUPPORT ACROSS THE ADIPOCYTIC DIFFERENTIATION AXIS: PHARMACOLOGICAL MODULATION TO ACCELERATE HEMATOPOIETIC RECOVERY

EHA Library, Frédérica Schyrr, 325508

INTEGRATED SINGLE CELL ANALYSIS IDENTIFIES UNIQUE MOLECULAR AND FUNCTIONAL FEATURES OF EXTRAMEDULLARY HAEMATOPOIESIS IN HUMANS

EHA Library, Nicole Mende, 325509

A STAT5B-CD9 AXIS DETERMINES SELF-RENEWAL IN HEMATOPOIETIC AND LEUKEMIC STEM CELLS

EHA Library, Veronika Sexl, 325510

DENATONIUM AS BITTER TASTE RECEPTOR AGONIST AFFECTS THE CLONOGENIC CAPACITY AND DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS

EHA Library, Valentina Pensato, 325511

CLONAL HAEMATOPOIESIS: USING LONGITUDINAL COHORT DATA TO STUDY THE AGEING HUMAN HAEMATOPOIETIC SYSTEM

EHA Library, Kristina Kirschner, 325512

CHIP CLONE SIZE CORRELATES WITH EPIGENETIC AGE ACCELERATION

EHA Library, Jasper David Feldkamp, 325513

CHANGES IN BONE MARROW STROMAL MICROENVIRONMENT PROGENITOR CELLS IN PATIENTS WITH HEMOBLASTOSIS

EHA Library, Nataliya Petinati, 325514

PREVALENCE AND CLINICAL IMPACT OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IN PATIENTS UNDERGOING HEART TRANSPLANTATION.

EHA Library, Victoria Panagiota, 325515

KER-050, AN INHIBITOR OF TGF-Β SUPERFAMILY SIGNALING, OBSERVED TO HAVE A RAPID, DYNAMIC, AND DURABLE EFFECT ON ERYTHROPOIESIS.

EHA Library, Marina Feigenson, 325516

CROSSTALK BETWEEN NITRIC OXIDE AND GLUCOCORTICOID RECEPTOR IS DISPENSABLE FOR INITIAL STRESS-INDUCED ERYTHROID PROGENITOR CELL EXPANSION

EHA Library, Sanja Momčilović, 325517

STUDY OF THE MACROPHAGE POLARISATION CONTINUUM WITH RELEVANCE TO COVID19

EHA Library, Charlotte Severn, 325518

NICHE HEALTH MAINTAINS SURVIVAL

EHA Library, Christina Schreck, 325519

IMMUNE STATUS IN HEMATOLOGICAL CANCER PATIENTS AFTER COVID19

EHA Library, Inna Kamaeva, 325520

RING CHROMOSOMES IN HEMATOLOGICAL MALIGNANCIES

EHA Library, Kalliopi Manola, 325521

CLINICAL OUTCOMES OF RELAPSED HODGKIN LYMPHOMA PATIENTS AFTER CONTEMPORARY FIRST-LINE TREATMENT: RESULTS FROM THE GERMAN HODGKIN STUDY GROUP

EHA Library, Paul Bröckelmann, 325522

MODIFICATION OF ESCALATED BEACOPP WITH DACARBAZINE SUBSTITUTION REDUCES TOXICITY WHILE MAINTAINING EFFICACY FOR THE TREATMENT OF ADVANCED-STAGE HODGKIN LYMPHOMA.

EHA Library, Anna Santarsieri, 325523

LONG-TERM FOLLOW-UP AND BIOMARKER ANALYSES OF RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED WITH BRENTUXIMAB VEDOTIN AND DHAP: THE HOVON/LLPC TRANSPLANT BRAVE STUDY

EHA Library, Julia Driessen, 325524

IMPACT OF THE FIRST COVID-19 LOCKDOWN IN GERMANY ON THE RATE OF ACUTE INFECTIONS DURING INTENSIVE CHEMOTHERAPY FOR HODGKIN LYMPHOMA

EHA Library, Anne Sophie Jacob, 325525

THYMUS AND ACTIVATION-REGULATE CHEMOKINE (TARC) IS A RELIABLE TUMOR MARKER FOR BOTH DIAGNOSIS AND MONITORING CLASSICAL HODGKIN LYMPHOMA

EHA Library, Szandra Boldizsar, 325526

BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN ADOLESCENTS AND YOUNG ADULTS (AYAS) WITH STAGE III OR IV HODGKIN LYMPHOMA: A SUBGROUP ANALYSIS FROM THE PHASE 3 ECHELON-1 STUDY

EHA Library, Andrew P. Grigg, 325527

BRENTUXIMAB VEDOTIN- CONTAINING REGIMENS FOR THE TREATMENT OF RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN CLINICAL PRACTICE: FOCUS ON SUBSEQUENT THERAPIES.

EHA Library, Evgeniya Borzenkova, 325528

OUTCOMES OF PATIENTS WITH INDETERMINATE RESPONSE DURING PD-1 INHIBITOR THERAPY FOR RELAPSED AND REFRACTORY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Liudmila Fedorova, 325529

PRELIMINARY RESULTS OF THE COMBINATION OF NIVOLUMAB AND DHAP IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (NIVO-DHAP) AS A SECOND-LINE THERAPY BEFORE AUTOLOGOUS HSCT

EHA Library, Nikita Mochkin, 325530

SUBCLINICAL COAGULATION DISORDERS IN NEWLY DIAGNOSED PATIENTS WITH HODGKIN LYMPHOMA (HL): A PHENOMENON RELATED TO THROMBOINFLAMMATION

EHA Library, Theodoros Vassilakopoulos, 325531

OUTCOME AND PROGNOSTIC FACTORS IN PATIENTS WITH ADVANCED HODGKIN LYMPHOMA WHO REMAIN PET/CT-POSITIVE AFTER 2 CYCLES OF ABVD: REAL-LIFE EXPERIENCE IN A MULTICENTER SETTING IN GREECE.

EHA Library, Theodoros Vassilakopoulos, 325532

TREATMENT OF HODGKIN DISEASE IN RELAPSE AFTER 3 LINES INCLUDING BRENTUXIMAB WITH DOSE DENSE PROTOCOL PLUS LENALIDOMIDE

EHA Library, Maher Salamoon, 325533

PET-STATUS AND PATIENTS WITH NEWLY HODGKIN LYMPHOMA (HL) PROGNOSIS: IS IT ALL THAT DEFINITIVE?

EHA Library, Olga Novosad, 325534

EVALUATION OF GONADAL FUNCTION IN YOUNG MEN AND WOMEN DIAGNOSED WITH HODGKIN LYMPHOMA

EHA Library, Angeliki Georgopoulou, 325535

ENDOCRINE DISORDERS IN HODGKIN LYMPHOMA SURVIVORS

EHA Library, Mariia Voytko, 325536

GERMAN EVIDENCE-BASED LIVING GUIDELINE ON DIAGNOSIS, THERAPY AND FOLLOW-UP OF ADULT PATIENTS WITH HODGKIN LYMPHOMA

EHA Library, Angela Aldin, 325537

TREATMENT OUTCOMES OF HODGKIN LYMPHOMA: PET GUIDED DE-ESCALATION IN REAL WORLD

EHA Library, Susmita Dasgupta, 325538

THE PROGNOSTIC VALUE OF PD-L1 AND PD-L2 LOCI ALTERATIONS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA TREATED WITH NIVOLUMAB

EHA Library, Lepik Kirill, 325539

IBRUTINIB PLUS RITUXIMAB (IR) VS PLACEBO PLUS RITUXIMAB (R) FOR WALDENSTROM’S MACROGLOBULINEMIA (WM): FINAL ANALYSIS AFTER FIVE YEARS OF FOLLOW-UP FROM THE RANDOMIZED PHASE 3 INNOVATE STUDY

EHA Library, Ramon Garcia-Sanz, 325540

PHASE 2 STUDY OF ZANUBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MAGNOLIA STUDY)

EHA Library, Stephen Opat, 325541

PRELIMINARY CLINICAL DATA FROM A PHASE 1B STUDY OF MAVORIXAFOR AND IBRUTINIB IN PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINEMIA WITH MYD88 AND CXCR4 MUTATIONS

EHA Library, Steven Treon, 325542

ROLE OF MAINTENANCE RITUXIMAB (MR) AFTER FIRST-LINE (1L) BENDAMUSTINE + RITUXIMAB (BR) OR R-CHOP IN PATIENTS (PTS) WITH MANTLE CELL LYMPHOMA (MCL) FROM A LARGE US REAL-WORLD (RW) COHORT

EHA Library, Gilles Salles, 325543

KTE-X19 VERSUS STANDARD OF CARE FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA PREVIOUSLY TREATED WITH BRUTON TYROSINE KINASE INHIBITORS: REAL-WORLD EVIDENCE FROM EUROPE

EHA Library, Georg Hess, 325544

OUTCOMES WITH KTE-X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ZUMA-2 WHO HAD PROGRESSION OF DISEASE WITHIN 24 MONTHS OF DIAGNOSIS

EHA Library, Michael Wang, 325545

EARLY SAFETY AND EFFICACY FINDINGS OF AUTO1 (CAT19), A FAST-OFF RATE CD19 CAR, IN RELAPSED /REFRACTORY INDOLENT B CELL LYMPHOMAS

EHA Library, Claire Roddie, 325546

ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL): LONG-TERM EFFICACY AND SAFETY RESULTS FROM A PHASE 2 STUDY

EHA Library, Yuqin Song, 325547

HIGH-RISK MANTLE CELL LYMPHOMA IN THE LYMA TRIAL: A LYSA STUDY.

EHA Library, Morgane Cheminant, 325548

UPDATED OUTCOMES WITH AXICABTAGENE CILOLEUCEL (AXI-CEL) RETREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA IN ZUMA-5

EHA Library, Julio Chavez, 325549

A PHASE ⅡSTUDY OF A SELECTIVE PI3KΔ INHIBITOR YY-20394 IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA.

EHA Library, lugui qiu, 325550

PREVALENCE OF SECOND CANCER DURING LONG TERM FOLLOW-UP IN HAIRY CELL LEUKEMIA PATIENTS TREATED WITH CLADRIBINE: A THIRTY-YEAR EXPERIENCE

EHA Library, Marianna Criscuolo, 325551

RISK FACTORS FOR POD24 IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Tingting Zhang, 325552

RITUXIMAB, BENDAMUSTINE, AND CYTARABINE (R-BAC) COMPARED WITH RITUXIMAB AND BENDAMUSTINE (BR) IN PREVIOUSLY UNTREATED ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA (BE-VE-BAC STUDY)

EHA Library, Giulia Bega, 325553

PRIMARY THERAPY AND RELATIVE SURVIVAL IN PATIENTS WITH LYMPHOPLASMACYTIC LYMPHOMA/WALDENSTRÖM’S MACROGLOBULINEMIA (LPL/WM): A POPULATION-BASED STUDY IN THE NETHERLANDS, 1989-2018

EHA Library, Karima Amaador, 325554

TREATMENT PATTERNS AND OUTCOMES OF ELDERLY PATIENTS WITH MANTLE CELL LYMPHOMA UNFIT FOR STANDARD IMMUNOCHEMOTHERAPY: A UK AND IRELAND ANALYSIS

EHA Library, Alexandros Rampotas, 325555